In 2024 and as of 30 of April, approximately 240 000 CHIKVD cases and over 90 deaths have been reported worldwide. A total of 18 countries reported CHIKVD cases from the Americas (11), Asia (6), and Africa (1).
Recent ECDC data show that despite progress in prevention and control efforts, the hepatitis B and hepatitis C viruses (HBV and HCV) continue to pose significant public health challenges in the European Union and European Economic Area (EU/EEA).
This report provides updated baseline data for monitoring future changes in the distribution of autochthonous Crimean-Congo haemorrhagic fever and its associated vectors for Europe and its neighbouring areas.
Prevalence data from sources such as population surveys can be a useful complement to case based surveillance data for hepatitis B. Case-based surveillance has limitations as most diagnosed cases are chronic in nature and detection of cases depends largely on testing practices. Prevalence data can therefore contribute towards a fuller understanding of the epidemiology of hepatitis B.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.